Cited by

• Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.

  Burdo TH, Gartner S, Mauger D, Wigdahl B. Burdo TH, et al. J Neurovirol. 2004;10 Suppl 1:7-14. doi: 10.1080/753312746. J Neurovirol. 2004. PMID: 14982733
• Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.

  Wen J, Cheever T, Wang L, Wu D, Reed J, Mascola J, Chen X, Liu C, Pegu A, Sacha JB, Lu Y, Haigwood NL, Chen ISY. Wen J, et al. PLoS Pathog. 2021 Jul 20;17(7):e1009738. doi: 10.1371/journal.ppat.1009738. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34283885 Free PMC article.
• Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity.

  Louboutin JP, Agrawal L, Reyes BA, Van Bockstaele EJ, Strayer DS. Louboutin JP, et al. Antioxidants (Basel). 2014 May 16;3(2):414-38. doi: 10.3390/antiox3020414. Antioxidants (Basel). 2014. PMID: 26784879 Free PMC article.
• Neuroprotective activities of CEP-1347 in models of neuroAIDS.

  Eggert D, Dash PK, Gorantla S, Dou H, Schifitto G, Maggirwar SB, Dewhurst S, Poluektova L, Gelbard HA, Gendelman HE. Eggert D, et al. J Immunol. 2010 Jan 15;184(2):746-56. doi: 10.4049/jimmunol.0902962. Epub 2009 Dec 4. J Immunol. 2010. PMID: 19966207 Free PMC article.
• The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

  Jayadev S, Yun B, Nguyen H, Yokoo H, Morrison RS, Garden GA. Jayadev S, et al. J Neuroimmune Pharmacol. 2007 Dec;2(4):359-70. doi: 10.1007/s11481-007-9095-x. Epub 2007 Oct 20. J Neuroimmune Pharmacol. 2007. PMID: 18040854